Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix
- PMID: 19189849
- DOI: 10.1016/j.jviromet.2009.01.015
Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix
Abstract
A broad range of structural viral proteins has the ability to assemble into virus-like particles (VLPs). Under the condition that modified subunits are still competent to assemble into VLPs, they are epitope delivery platforms suitable for vaccination purposes. The insertion of foreign sequences can be detrimental for the formation of chimeric VLPs as a result of misfolded subunit proteins. Hence, a strategy was adopted to screen for locations allowing the use of shared residues between the wildtype subunit sequence and the foreign insert. The insertion of a cysteine-containing sequence of hepatitis C virus (HCV) envelope protein 2 (E2) without adding an additional cysteine residue retained the ability of recombinant small hepatitis B surface antigen (HBsAg-S) to form secretion competent VLPs. A cysteine residue shared by the insert and the template protein avoided the formation of non-native disulfide bonds, and allowed the formation of VLPs. The chimeric HBsAg-S VLPs were similar to wildtype VLPs in density exposing the inserted foreign epitope and being immunogenic. Overall, the use of shared sequences between the insert and the subunit will facilitate the design of chimeric VLPs carrying multiple epitopes.
Similar articles
-
Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.Antivir Ther. 2007;12(4):477-87. Antivir Ther. 2007. PMID: 17668556
-
Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.Mol Immunol. 2006 Feb;43(5):436-42. doi: 10.1016/j.molimm.2005.03.002. Epub 2005 Apr 2. Mol Immunol. 2006. PMID: 16337486
-
Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.J Virol. 2006 Apr;80(8):3975-84. doi: 10.1128/JVI.80.8.3975-3984.2006. J Virol. 2006. PMID: 16571814 Free PMC article.
-
[Hepatitis B virus core protein as an epitope vaccine carrier: a review].Sheng Wu Gong Cheng Xue Bao. 2010 Apr;26(4):431-8. Sheng Wu Gong Cheng Xue Bao. 2010. PMID: 20575429 Review. Chinese.
-
The core antigen of hepatitis B virus as a carrier for immunogenic peptides.Biol Chem. 1999 Mar;380(3):277-83. doi: 10.1515/BC.1999.038. Biol Chem. 1999. PMID: 10223329 Review.
Cited by
-
The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine.Front Microbiol. 2017 Nov 7;8:2163. doi: 10.3389/fmicb.2017.02163. eCollection 2017. Front Microbiol. 2017. PMID: 29163442 Free PMC article. Review.
-
Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.J Virol. 2015 Nov;89(22):11312-22. doi: 10.1128/JVI.01123-15. Epub 2015 Sep 2. J Virol. 2015. PMID: 26339047 Free PMC article.
-
Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.Microb Cell Fact. 2016 Apr 13;15:62. doi: 10.1186/s12934-016-0460-4. Microb Cell Fact. 2016. PMID: 27075377 Free PMC article.
-
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.Vaccines (Basel). 2020 Jun 10;8(2):294. doi: 10.3390/vaccines8020294. Vaccines (Basel). 2020. PMID: 32532076 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources